Topical co-delivery of platelet rich fibrin and tranexamic acid does not decrease blood loss in primary total knee arthroplasty compared to the standard of care: a prospective, randomized, controlled trial

被引:6
|
作者
Tandogan, Reha N. [1 ]
Polat, Metin [1 ]
Beyzadeoglu, Tahsin [2 ,3 ]
Karabulut, Erdem [4 ]
Yildirim, Kerem [3 ,5 ]
Kayaalp, Asim [1 ]
机构
[1] Ortoklin & Cankaya Orthoped, Cinnah Caddesi 51-4, TR-06680 Ankara, Turkey
[2] Halic Univ, Orthopaed & Traumatol, Bagdat Cad 333 Erenkoy, TR-34738 Istanbul, Turkey
[3] Beyzadeoglu Clin, Bagdat Cad 333 Erenkoy, TR-34738 Istanbul, Turkey
[4] Hacettepe Univ, Dept Biostat, Sihhiye Campus, Ankara, Turkey
[5] Istanbul Gelisim Univ, Orthopaed & Traumatol, Bagdat Cad 333 Erenkoy, TR-34738 Istanbul, Turkey
关键词
Platelet rich fibrin; Tranexamic acid; Total knee arthroplasty; Blood loss; TOURNIQUET USE; MANAGEMENT STRATEGIES; CLINICAL-TRIAL; METAANALYSIS; TRANSFUSION; SUPERIOR; EFFICACY; SEALANT; HIP;
D O I
10.1007/s00167-020-05938-1
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Purpose The purpose of this study was to evaluate the efficacy of intra-operative co-administration of tranexamic acid (TA) and platelet rich fibrin (PRF) using a proprietary co-delivery system on the amount of blood loss, early functional outcomes and wound complications after primary total knee arthroplasty (TKA). The intervention was compared to the standard of care (combined intravenous & topical TA) in a prospective, randomized, blinded setting. Methods 80 patients undergoing primary cemented TKA without tourniquet were prospectively randomized into control (combined intravenous and topical TA) and PRF (intra-venous TA and co-delivery of topical PRF and TA) groups after informed consent. Total blood loss, drainage blood loss, knee range of motion, VAS pain scores, length of stay and wound complications were analysed. Data collection was performed in a double blind manner on days 1, 3 and 21. Results There was no statistically significant difference in drainage blood loss (550 ml vs. 525 ml,p = 0.643), calculated total blood loss on day 1 (401 ml vs. 407 ml,p = 0.722), day 3 (467 ml vs 471 ml,p = 0.471) and day 21 (265 ml vs. 219 ml,p = 0.082) between the PRF and control groups respectively. The PRF group had a small but statistically significant increase in median knee extension in the early post-operative period, however this difference evened out at 3 weeks. No significant difference could be demonstrated between the PRF and control groups in length of stay, VAS pain scores, narcotic usage, wound complications and knee flexion at all time points. Conclusions The topical co-delivery of PRF and TA does not significantly decrease blood loss in primary TKA compared to the standard of care. Slightly better active knee extension in the first 3 postoperative days can be achieved, however this benefit is not clinically relevant.
引用
收藏
页码:519 / 528
页数:10
相关论文
共 50 条
  • [21] Multi-route applications of tranexamic acid to reduce blood loss after total knee arthroplasty: a randomized controlled trial
    Zhang, Shenqi
    Wang, Chengbin
    Shi, Lei
    Xue, Qingyun
    MEDICINE, 2019, 98 (30)
  • [22] Reducing blood loss in simultaneous bilateral total knee arthroplasty: Combined intravenous-intra-articular tranexamic acid administration. A prospective randomized controlled trial
    Karaaslan, Fatih
    Karaoglu, Sinan
    Mermerkaya, Musa Ugur
    Baktir, Ali
    KNEE, 2015, 22 (02) : 131 - 135
  • [23] Topical tranexamic acid in cemented primary total knee arthroplasty without tourniquet: a prospective randomized study
    Morales Santias, Manuel
    Mas Martinez, Jesus
    Sanz-Reig, Javier
    Martinez Gimenez, Enrique
    Verdu Roman, Carmen
    Bustamante Suarez de Puga, David
    EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY, 2020, 30 (06) : 1003 - 1008
  • [24] Combined intravenous and intra-articular tranexamic acid administration in total knee arthroplasty for preventing blood loss and hyperfibrinolysis A randomized controlled trial
    Zhang, Yi-Min
    Yang, Bo
    Sun, Xue-Dong
    Zhang, Zhen
    MEDICINE, 2019, 98 (07)
  • [25] A Prospective Double-Blind Placebo Controlled Trial of Topical Tranexamic Acid in Total Knee Arthroplasty
    Georgiadis, Andrew G.
    Muh, Stephanie J.
    Silverton, Craig D.
    Weir, Robb M.
    Laker, Michael W.
    JOURNAL OF ARTHROPLASTY, 2013, 28 (08) : 78 - 82
  • [26] Hemostatic effect of oxidized regenerated cellulose vs. topical tranexamic acid in total knee arthroplasty-a prospective randomized controlled trial
    Li, Bowei
    Pan, Wenjie
    Ma, Jianbing
    Huang, Yuanchi
    FRONTIERS IN SURGERY, 2025, 11
  • [27] Efficacy of Different Doses of Intra-Articular Tranexamic Acid for Reducing Blood Loss and Lower Limb Swelling After Total Knee Arthroplasty: A Prospective, Randomized, Controlled Trial
    Ye, Shuwei
    Luo, Yue
    Li, Qianhao
    Cai, Lijun
    Kang, Pengde
    ORTHOPAEDIC SURGERY, 2025, 17 (03) : 733 - 743
  • [28] Comparison of topical versus intravenous tranexamic acid in primary total knee arthroplasty: A meta-analysis of randomized controlled and prospective cohort trials
    Wang, Hao
    Shen, Bin
    Zeng, Yi
    KNEE, 2014, 21 (06) : 987 - 993
  • [29] Intravenous tranexamic acid reduces total blood loss in reverse total shoulder arthroplasty: a prospective, double-blinded, randomized, controlled trial
    Vara, Alexander D.
    Koueiter, Denise M.
    Pinkas, Daphne E.
    Gowda, Ashok
    Wiater, Brett P.
    Wiater, J. Michael
    JOURNAL OF SHOULDER AND ELBOW SURGERY, 2017, 26 (08) : 1383 - 1389
  • [30] Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: a prospective randomized controlled trial
    Lee, Sang Hak
    Cho, Kye-Youl
    Khurana, Sumit
    Kim, Kang-Il
    KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2013, 21 (11) : 2611 - 2617